Our vision is to be the most customer-centric CRO on earth. We are conscious that our customers look for ways to accelerate trial execution. So we deliver on our vision by delivering faster, smarter, scientific and affordable solutions. We work vigorously to design patient- and PI-centric trials, to reduce the trial delivery timelines and costs and to drive smarter decision-making processes through data insights.

Pivotal was born and raised in 2001 surrounded by an environment of high scientific tenure and drive. Our founder, Dr. Ibrahim Farr, launched Pivotal to share and implement scientific strategies and best project practices that make clinical trials more efficient and maximize our client’s drug development programs’ value chain. As a company with some 200 employees and operating in more than 20 countries we have built focused specialization across all therapeutic areas and founded a strong innovative therapies and early phases hub that enables us to tackle our customers most difficult challenges. After almost 22 years of hands-on experience, we master clinical research. 

Pivotal has forged an aspirational vision of a digitally and data-enabled, growth-oriented future. We dive deep into clinical trials by leveraging our near real time advanced insights platform. We discover data-driven insights to anticipate trial risks and predict their impact. This has made us an efficient, agile and resilient company, very focused on our customers.  We are a technology-savvy organization.

Our approach to clinical research can be summarized in our Innovative Organizational Model: connected with the clinical research and technology ecosystem, scientifically, medically data-driven, agile and customer-centric.


Clinical Trials

Health Care

Life Sciences

Medical Devices

Research

Therapeutics

Pivotal

Ibrahim Farr

Ignacio Marín García

Lourdes Huarte

Lidia Farr

José Javier Garcia

Pivotal

Org chart

Similar companies